Early differentiation of acute cerebrovascular conditions is important for timely clinical management, while blood-based markers that could complement established diagnostic approaches remain under investigation. This exploratory case-control study evaluated the circulating expression and diagnostic performance of seve...
S. Battakova, M. Grigolashvili, Irina Kadyrova et al.· PLoS ONE· 0 citations
A personalized approach to the treatment of generalized myasthenia gravis should take into account serological status, disease activity, the frequency of exacerbations, comorbidities, tolerance to treatment, the possibility of reducing the dose of glucocorticoids, and the patient's preferences.
O. Boyko, T. Alekseeva, O. Gilvanova et al.· Neurology, neuropsychiatry,...· 0 citations
Introduction Early differential diagnosis of acute cerebrovascular events remains a key clinical challenge, particularly during the hyperacute phase. This study aimed to assess plasma amino acid profiles and their dynamic changes as potential biomarkers and to evaluate their contribution to diagnostic accuracy. Methods...
S. Battakova, M. Grigolashvili, D. Klyuyev et al.· Frontiers in Neurology· 0 citations
The findings confirm the significant role of polymorphisms in the IL6, SIRT1 and MMP9 genes as potential genetic markers of an increased risk of developing MS and NMOSD in the studied population.
D. Kasatkin, A. Menshikh, O. D. Samoilova et al.· Neurology, neuropsychiatry,...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.